The U.S. Food and Drug Administration (FDA) announced the approval and emergency use authorization (EUA) of updated Pfizer and Moderna COVID-19 vaccines for 2023-2024. The development highlights the FDA’s acknowledgment that previous vaccine versions were ineffective against newer variants like Omicron XBB.1.5. Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and ...
Read more »